Multiple endocrine neoplasia type 1

British Journal of Surgery

Volumn 90, Issue 4, 2003, Pages 383-385

  Skogseid, B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GASTRIN; METHIONINE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA;

ADRENAL CORTEX TUMOR; AUTOSOMAL DOMINANT DISORDER; BENIGN TUMOR; BIOCHEMISTRY; BRONCHUS CARCINOID; CANCER GROWTH; CANCER PREVENTION; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER THERAPY; CHROMOSOME 11Q; CORRELATION ANALYSIS; DISEASE COURSE; DUODENUM CANCER; EDITORIAL; ENDOCRINE DISEASE; ENDOCRINE TUMOR; FAMILY; GENE INACTIVATION; GENE MAPPING; GENETIC DISORDER; GENETIC SCREENING; GENOTYPE; GERM LINE; HEMANGIOFIBROMA; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS ADENOMA; INTESTINE CANCER; KIDNEY DISEASE; LIPOMA; LYMPH NODE METASTASIS; MEN 1 GENE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE; PANCREAS TUMOR; PHENOTYPE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECURRENT DISEASE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STOMACH CANCER; SUPPRESSOR GENE; SYMPTOMATOLOGY; THYMUS CANCER; ZOLLINGER ELLISON SYNDROME; ADOLESCENT; ARTICLE; GENETICS; MIDDLE AGED; ONSET AGE; PEDIGREE; THYROID TUMOR;

ADOLESCENT; AGE OF ONSET; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; PEDIGREE; THYROID NEOPLASMS;

EID: 0037391288     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4110     Document Type: Editorial

References (9)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16: 363-371.
2. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome II and is lost in insulinoma. Nature 1988; 332: 85-87.
3. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-407.
4. Guo SS, Sawicki MP. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. Mol Endocrinol 2001; 15: 1653-1664.
5. Skogseid B, Eriksson B, Lundqvist G, Lorelius LE, Rastad J, Wide L et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991; 73: 281-287.
6. Skogseid B, Oberg K, Eriksson B, Juhlin C, Granberg D, Akerstrom G et al. Surgery. for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 1996; 20: 872-876.
7. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 2001; 86: 5282-5293.
8. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. Lethality of multiple endocrine neoplasia type I. World J Surg 1998; 22: 581-586.
9. Dean PG, van Heerden JA, Farley DR, Thompson GB, Grant CS, Harmsen WS et al. Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg 2000; 24: 1437-1441.